MRNA
Moderna Inc
158.10$
+8.5%
vs. previous close
Closing price · As of: Sep 17, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 0.0% | – | 13.9% | 10.0% | 370.6% | 1,033.2% | 2.9% | 14.8% | 28.7% | 68.5% | 45.8% | 44.7% | |
| 100.0% | – | 86.1% | 90.0% | -270.6% | 100.0% | 97.1% | 85.2% | 71.3% | 31.5% | 54.2% | 55.3% | |
| 137.2% | – | 253.4% | 199.4% | 370.6% | 1,033.2% | 499.2% | 11.2% | 17.5% | 70.8% | 142.0% | 161.1% | |
| 666.8% | – | 53.0% | 31.4% | 76.9% | 228.2% | 68.6% | 3.2% | 5.4% | 19.6% | 32.1% | 52.4% | |
| 0.0% | – | 292.5% | 220.9% | 437.3% | 1,236.1% | 375.1% | 10.3% | 21.4% | 93.4% | 177.6% | 213.5% | |
| -704.0% | – | -206.4% | -130.9% | -337.3% | -1,136.1% | -278.0% | 75.0% | 49.9% | -61.9% | -123.3% | -158.1% | |
| 0.0% | – | 0.0% | 0.1% | 2.5% | 13.8% | 3.6% | 0.1% | 0.2% | 0.6% | 0.8% | 0.5% | |
| -1,296.4% | – | -198.5% | -124.4% | -313.8% | -1,071.5% | -271.2% | 74.9% | 50.7% | -57.6% | -112.8% | -142.4% | |
| 0.0% | – | 1.0% | 0.0% | 0.3% | -1.4% | 0.9% | 6.1% | 6.4% | 11.3% | -1.4% | 2.8% | |
| -1,295.4% | – | -199.5% | -124.3% | -314.0% | -1,070.1% | -272.2% | 68.8% | 44.3% | -68.8% | -111.3% | -145.2% | |
| – | – | -192.5% | -114.3% | -317.0% | -1,071.5% | -266.6% | 76.3% | 52.7% | -47.9% | -106.1% | -131.3% |
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.